These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32761175)

  • 41. Baicalein enhances the effect of low dose Levodopa on the gait deficits and protects dopaminergic neurons in experimental Parkinsonism.
    Zheng ZV; Cheung CY; Lyu H; Chan HY; Li Y; Bian ZX; Wang KKW; Poon WS
    J Clin Neurosci; 2019 Jun; 64():242-251. PubMed ID: 30905662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation.
    Zhu H; Xiao F; Xiao Y; Guo Y; Shan X; Zhang Z; Zhang L; Guo H
    J Neuroinflammation; 2023 Dec; 20(1):304. PubMed ID: 38110963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroprotective Effects of Baicalein on Acrolein-induced Neurotoxicity in the Nigrostriatal Dopaminergic System of Rat Brain.
    Zhao WZ; Wang HT; Huang HJ; Lo YL; Lin AM
    Mol Neurobiol; 2018 Jan; 55(1):130-137. PubMed ID: 28866823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice.
    Manocha GD; Floden AM; Puig KL; Nagamoto-Combs K; Scherzer CR; Combs CK
    Mol Neurodegener; 2017 Feb; 12(1):17. PubMed ID: 28196514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of electroacupuncture on Nrf2/NLRP3/Caspase-1 pathway mediated-pyroptosis in mice with Parkinson's disease.
    Zhang XL; Hu MN; Rong Z; Li YN; Wang Y; Ma J
    Zhen Ci Yan Jiu; 2024 Jan; 49(1):15-22. PubMed ID: 38239134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord.
    Zhang J; Wang M; Zhao Y; Zhang Y; Gao Y; Zhang X; Yang G
    Neurosci Lett; 2022 Jun; 781():136669. PubMed ID: 35490905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring the Neuroprotective Mechanism of Curcumin Inhibition of Intestinal Inflammation against Parkinson's Disease Based on the Gut-Brain Axis.
    Zhong L; Cai B; Wang Q; Li X; Xu W; Chen T
    Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson's Disease.
    Qiao C; Zhang LX; Sun XY; Ding JH; Lu M; Hu G
    Mol Neurobiol; 2017 Aug; 54(6):4292-4302. PubMed ID: 27339879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson's disease model via a β-arrestin2-biased mechanism.
    Zhu J; Sun T; Zhang J; Liu Y; Wang D; Zhu H; Yao H; Ding J; Hu G; Lu M
    Brain Behav Immun; 2020 Nov; 90():259-271. PubMed ID: 32861720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levodopa Improves Behavioral Deficits of Mice with Parkinson's Disease Symptoms via Curbing NLRP3 Inflammasome Activation and Enhancing Tyrosine Hydroxylase Levels in the Striatum and Substantia Nigra.
    Chen X; Wang Z; Yang W; Fu Y
    J Integr Neurosci; 2024 Jan; 23(1):2. PubMed ID: 38287845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson's Disease via Regulating miR-7/NLRP3 Pathway.
    Cao B; Wang T; Qu Q; Kang T; Yang Q
    Neuroscience; 2018 Sep; 388():118-127. PubMed ID: 30031125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Programmed Death-1 Deficiency Aggravates Motor Dysfunction in MPTP Model of Parkinson's Disease by Inducing Microglial Activation and Neuroinflammation in Mice.
    Cheng YY; Chen BY; Bian GL; Ding YX; Chen LW
    Mol Neurobiol; 2022 Apr; 59(4):2642-2655. PubMed ID: 35142987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson's Disease Model.
    Huang S; Liu H; Lin Y; Liu M; Li Y; Mao H; Zhang Z; Zhang Y; Ye P; Ding L; Zhu Z; Yang X; Chen C; Zhu X; Huang X; Guo W; Xu P; Lu L
    Front Pharmacol; 2020; 11():618787. PubMed ID: 33584302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease.
    Zhang M; He Q; Chen G; Li PA
    Neurodegener Dis; 2020; 20(2-3):73-83. PubMed ID: 33176317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons.
    Li FQ; Wang T; Pei Z; Liu B; Hong JS
    J Neural Transm (Vienna); 2005 Mar; 112(3):331-47. PubMed ID: 15503194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease.
    Zhang C; Zhao M; Wang B; Su Z; Guo B; Qin L; Zhang W; Zheng R
    Redox Biol; 2021 Nov; 47():102134. PubMed ID: 34600334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feruloylated oligosaccharides ameliorate MPTP-induced neurotoxicity in mice by activating ERK/CREB/BDNF/TrkB signalling pathway.
    Ding Y; Zhou M; Zheng R; Ma R; Deng J; Hao WZ; Wang L; Zhang JC; Ho CT; Huang JQ
    Phytomedicine; 2023 Jan; 108():154512. PubMed ID: 36288652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.